ML

Michael Joseph Luzzio

Pfizer: 16 patents #226 of 5,153Top 5%
ST Skyhawk Therapeutics: 11 patents #1 of 8Top 15%
NA Novartis Ag: 8 patents #480 of 5,128Top 10%
GW Glaxo Wellcome: 5 patents #25 of 449Top 6%
SL Smithkline Beecham Limited: 4 patents #325 of 1,624Top 25%
GL Glaxo Group Limited: 2 patents #493 of 1,368Top 40%
AL Astex Therapeutics Limited: 1 patents #143 of 199Top 75%
BM Biogen Ma: 1 patents #201 of 400Top 55%
AP Agouron Pharmaceuticals: 1 patents #185 of 327Top 60%
VE Verastem: 1 patents #10 of 20Top 50%
📍 Noank, CT: #1 of 27 inventorsTop 4%
🗺 Connecticut: #483 of 34,797 inventorsTop 2%
Overall (All Time): #56,035 of 4,157,543Top 2%
49
Patents All Time

Issued Patents All Time

Showing 26–49 of 49 patents

Patent #TitleCo-InventorsDate
7820648 Pyrimidine derivatives for the treatment of abnormal cell growth Samit Kumar Bhattacharya, Donn Wishka, Gonghua Pan, Arthur Douglas Brosius, Joel Arcari +3 more 2010-10-26
7741336 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2010-06-22
7674796 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2010-03-09
7351712 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2008-04-01
7235562 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2007-06-26
7208499 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2007-04-24
7145008 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2006-12-05
7122670 Selective synthesis of CF3-substituted pyrimidines John Charles Kath, Daniel Tyler Richter 2006-10-17
7109337 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2006-09-19
7109335 Pyrimidine derivatives for the treatment of abnormal cell growth John Charles Kath 2006-09-19
7105529 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects Stephen Thomas Davis, Scott Howard Dickerson, Stephen Frye, Philip Anthony Harris, Robert Neil Hunter, III +4 more 2006-09-12
7071217 Substituted oxindole derivatives as tyrosine kinase inhibitors Scott Howard Dickerson, Robert Neil Hunter, III, Lee Frederick Kuyper, Karen Elizabeth Lackey, Edgar Raymond Wood, III 2006-07-04
7019147 Benzimidazole derivatives useful as antiproliferative agents Wayne E. Barth, Joseph P. Lyssikatos 2006-03-28
6995171 Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents Christopher Lowell Autry, Matthew Arnold Marx 2006-02-07
6964961 Thiophene derivatives useful as anticancer agents Bingwei Yang, Matthew Arnold Marx 2005-11-15
6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Stephen Thomas Davis, Scott Howard Dickerson, Stephen Frye, Philip Anthony Harris, Robert Neil Hunter, III +4 more 2003-04-01
6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Stephen Thomas Davis, Scott Howard Dickerson, Philip Anthony Harris, Robert Neil Hunter, III, Lee Frederick Kuyper +2 more 2002-05-14
6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors Stephen Thomas Davis, Scott Howard Dickerson, Philip Anthony Harris, Robert Neil Hunter, III, Lee Frederick Kuyper +3 more 2002-04-09
6172064 Formamides as therapeutic agents Robert Carl Andrews, Marc W. Andersen, David John Cowan, David Norman Deaton, Scott Howard Dickerson +4 more 2001-01-09
6100273 Water soluble camptothecin derivatives Jeffrey Besterman, Michael G. Evans, Karen Elizabeth Lackey, Michael Peel, Daniel Sternbach 2000-08-08
6090825 Oxazole derivatives as antagonists of alpha 1C andrenergic receptors Robert Carl Andrews, Peter J. Brown, Rodolfo Cadilla, David Harold Drewry, Brian Edward Marron +1 more 2000-07-18
5559235 Water soluble camptothecin derivatives Jeffrey Besterman, Michael G. Evans, Peter L. Myers 1996-09-24
5223506 Cyclic antitumor compounds Jeffrey Besterman, Michael G. Evans, M. Ross Johnson, Milana Dezube, Salvatore Profeta, Jr. 1993-06-29
5126351 Antitumor compounds Jeffrey Besterman, Michael G. Evans, M. Ross Johnson 1992-06-30